Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers
Chen, Wu1; Yang, Wen2; Chen, Pengyu2; Huang, Yongzhuo3; Li, Feng1
刊名ACS APPLIED MATERIALS & INTERFACES
2018-12-05
卷号10期号:48页码:41118-41128
关键词disulfiram copper diethyldithiocarbamate drug resistance prostate cancer nanoparticle drug delivery paraptosis
ISSN号1944-8244
DOI10.1021/acsami.8b14940
文献子类Article
英文摘要Disulfiram (DSF), an alcohol-aversion drug, has been explored for cancer treatment. Copper diethyldithiocarbamate (Cu(DDC)(2)) complex formed by DSF and copper ions is a major active ingredient for its anticancer activity. Direct administration of Cu(DDC)(2) is a promising strategy to enhance the anticancer efficacy of DSF. However, efficient drug delivery remains a significant challenge for Cu(DDC)(2) and hinders its clinical use. In this study, we developed a facile stabilized metal ion ligand complex (SMILE) method to prepare Cu(DDC)(2) nanoparticles (NPs). The SMILE method could prepare Cu(DDC)(2) NPs with different types of stabilizers including 1,2-distearoyl-sn-glycerol-3-phosphoethanolamine poly(ethylene glycol) (PEG) 2000, D-alpha-tocopherol PEG 1000 succinate, methoxy PEG 5000-b-poly(L-lactide) 5000, and other generally recognized as safe excipients approved by the US Food and Drug Administration. The optimized formulations demonstrated excellent drug-loading efficiency (close to 100%), high drug concentrations (increased drug concentration by over 200-fold compared to the traditional micelle formulation), and an optimal particle size in the sub-100 nm range. Cu(DDC)(2) NPs exhibited outstanding stability in serum for 72 h and can also be stored at room temperature for at least 1 month. The anticancer effects of Cu(DDC)(2) NP formulations were determined by multiple assays including 3-(4,5-dimethyl-thiazol-2-yl)2,5-diphenyl tetrazolium bromide assay, colony-forming assay, calcein-AM/propidium iodide staining, and others. Cu(DDC)(2) NPs showed excellent activity against drug-resistant prostate cancer cells and other cancer cells with a half-maximal inhibitory concentration (IC50) of around 100 nM. Our study also demonstrated that Cu(DDC)(2) NPs induced cell death in drug-resistant prostate cancer cells (DU145-TXR) through paraptosis, which is a nonapoptotic cell death. To our best knowledge, the SMILE method provides, for the first time, a simple yet efficient process for generating Cu(DDC)(2) NPs with high drug concentration, excellent loading efficiency, and desirable physicochemical properties. This method could potentially address drug delivery challenges of DSF/copper-based chemotherapy and facilitate its clinical translation.
资助项目Auburn University startup fund[00000000] ; National Science Foundation[CBET-1701363]
WOS关键词TARGETS CANCER ; CELL-DEATH ; IN-VITRO ; DELIVERY ; DIETHYLDITHIOCARBAMATE ; FORMULATION ; APOPTOSIS ; REVERSES ; THERAPY ; STRESS
WOS研究方向Science & Technology - Other Topics ; Materials Science
语种英语
出版者AMER CHEMICAL SOC
WOS记录号WOS:000452694100019
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/279471]  
专题药物制剂研究中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Huang, Yongzhuo; Li, Feng
作者单位1.Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA;
2.Auburn Univ, Mat Res & Educ Ctr, Mat Engn, Dept Mech Engn, Auburn, AL 36849 USA;
3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Chen, Wu,Yang, Wen,Chen, Pengyu,et al. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers[J]. ACS APPLIED MATERIALS & INTERFACES,2018,10(48):41118-41128.
APA Chen, Wu,Yang, Wen,Chen, Pengyu,Huang, Yongzhuo,&Li, Feng.(2018).Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.ACS APPLIED MATERIALS & INTERFACES,10(48),41118-41128.
MLA Chen, Wu,et al."Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers".ACS APPLIED MATERIALS & INTERFACES 10.48(2018):41118-41128.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace